4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0001780030-26-000006
Chief Financial Officer bought 13,634 shares at an average $23.92 ($326,127)
From the SEC's structured data for this filing
Trades in this filing
STEPHENSON BRIAN C · Chief Financial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-29 | Purchase : show line 1 in the form | +831 | $23.34 | $19,396 | 33,885 | I |
| 2026-06-30 | Purchase : show line 2 in the form | +1,910 | $22.95 | $43,835 | 35,795 | I |
| 2026-06-30 | Purchase : show line 3 in the form | +1,638 | $23.88 | $39,115 | 37,433 | I |
| 2026-06-30 | Purchase : show line 4 in the form | +4,255 | $24.98 | $106,290 | 41,688 | I |
| 2026-07-01 | Purchase : show line 5 in the form | +4,400 | $23.40 | $102,960 | 46,088 | I |
| 2026-07-01 | Purchase : show line 6 in the form | +600 | $24.22 | $14,532 | 46,688 | I |
| Open-market purchases · 13,634 sh · avg $23.92 · $326,127 | ||||||
Loading xslF345X06/form4-07022026_120749.xml…